Kate Samardzic

Kate Samardzic, Ph.D., is a Senior Consultant at Acsel Health since January 2023. Previously, Kate served as a Postdoctoral Researcher at Stanford University from September 2020 to January 2023 and as a Business Development Consultant at Maze Therapeutics from September 2021 to August 2022. Earlier experiences include a Venture Capital Intern role at Panacea Venture, a business development associate with Bio-Link Australia Pty. Ltd., and a Casual Academic at the University of Technology Sydney, where teaching responsibilities spanned various subjects across undergraduate and master's programs. Education credentials include a Ph.D. from the University of Technology Sydney, a CORe Credential of Readiness from Harvard Business School Online, and a certificate in Biomedical Innovation and Entrepreneurship from The University of Tokyo.